http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0778789-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e06a25c452c6c6531544245d3e2efee4 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-30 |
| filingDate | 1995-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b331fa623441421dafe19082a332058f |
| publicationDate | 1997-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0778789-A1 |
| titleOfInvention | Precise dosage control ionophoresis device for the transcutaneous delivery of an active ingredient to a patient |
| abstract | Device comprising a first electrode assembly (2) associating a first electrode (9) with a first container (10) enclosing the active ingredient, a second electrode assembly (3) associating a second electrode (11) with a second container (12) enclosing an electrolyte, at least one of the electrodes (9, 11) being an Ag/AgCl electrode, an ionophoretic electric signal generator (1) which can be connected to the electrodes and a unit (4) for monitoring the transcutaneous delivery of an active ingredient. The device of the invention is for controlling the transcutaneous delivery of active ingredients. |
| priorityDate | 1994-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 135.